Scientists, including one of Indian-origin, have developed a method to identify biomarkers for prostate cancer in urine that could make early screening for the disease as easy for men as personal pregnancy testing is for women.
The technique by University of California, Irvine researchers
to clearly identify clinically usable markers for prostate cancer in urine could facilitate commercially available, at-home urine tests.
The same technology could potentially be used for bladder and multiple myeloma cancers, which also shed identifiable markers in urine.
“Our goal is a device the size of a home pregnancy test priced around USD 10. You would buy it at the drugstore or the grocery store and test yourself,” said the study’s corresponding author, Reginald Penner, UC Irvine Chancellor’s Professor of chemistry.
“We’re on the verge of a very important breakthrough in a new era of personal health management,” Penner said.